中国癌症杂志 ›› 2019, Vol. 29 ›› Issue (9): 753-760.doi: 10.19401/j.cnki.1007-3639.2019.09.011

• 指南与共识 • 上一篇    

早期乳腺癌术后靶区勾画共识

杨昭志,孟 晋,马金利,梅 欣,陈星星,张晓萌,张 丽,王小方,石 薇,马学军,俞晓立,章 真,郭小毛   

  1. 复旦大学附属肿瘤医院放疗科,复旦大学上海医学院肿瘤学系,上海 200032
  • 出版日期:2019-09-30 发布日期:2019-11-20
  • 通信作者: 郭小毛 E-mail: guoxm1800@126.com

Early stage breast cancer postoperative target volume contouring

YANG Zhaozhi, MENG Jin, MA Jinli, MEI Xin, CHEN Xingxing, ZHANG Xiaomeng, ZHANG Li, WANG Xiaofang, SHI Wei, MA Xuejun, YU Xiaoli, ZHANG Zhen, GUO Xiaomao   

  1. Department of Radiation Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • Published:2019-09-30 Online:2019-11-20
  • Contact: GUO Xiaomao E-mail: guoxm1800@126.com

摘要: 背景与目的:国际上乳腺癌术后辅助放疗的临床靶体积(clinical target volume,CTV)勾画存在明显差异,有必要在单中心形成靶区勾画共识。方法:选取复旦大学附属肿瘤医院收治的2例乳腺癌患者,1例为保乳术后,另1例为乳房改良根治术后。分别进行模拟CT扫描。结果:复习了美国和欧洲的靶区勾画共识,结合已经发表的临床研究对靶区的定义以及自己的临床实践,经多次专家讨论,分别就保乳术后的瘤床、乳腺及改良根治术后的胸壁、区域淋巴结CTV进行了详细的定义。由1名医生在模拟CT上勾画,并将勾画好的靶区再送给各专家进行修改。结论:形成了一致的早期乳腺癌术后靶区勾画共识,有利于临床实践、教学及科研工作。

Abstract: Background and purpose: Significant difference exists in clinical target volume (CTV) delineation of postoperative radiotherapy for breast cancer internationally. It is necessary to have a consensus in single cancer center. Methods: We chose two typical breast cancer patients who treated in Fudan University Shanghai Cancer Center. One had conservative breast surgery and the other had modified mastectomy. Simulation computed tomography (CT) scan was used for these two patients, and data were transmitted to Varian treatment planning system. Results: We reviewed American and European consensus on breast cancer target volume delineation and the definitions of international phase 3 clinical trials. Combined with our own clinical practice, CTVs of breast, tumor bed, chest wall and regional lymph nodes were defined after many discussions by specialists. CTVs were delineated by one physician and modified by all participating experts. Conclusion: Consensus on early stage breast cancer target delineation was made in our center. This will benefit our clinical practice, teaching and research.